AML M5b
|
disease |
|
Neoplastic Process
|
6
|
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
Myelodysplastic Syndrome Acute Myeloid Leukemia
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
|
Neoplastic Process
|
8
|
|
0.010 |
None |
1.000 |
1 |
|
2000 |
2000 |
Limbic Encephalitis
|
disease |
Neoplasms; Infections; Nervous System Diseases
|
Disease or Syndrome
|
27
|
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Patent ductus arteriosus - persisting type
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Respiratory Tract Diseases; Cardiovascular Diseases
|
Congenital Abnormality
|
30
|
10
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
RETINITIS PIGMENTOSA 1
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Eye Diseases
|
Disease or Syndrome
|
32
|
21
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Myelomonocytic leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
36
|
|
0.300 |
None |
|
0 |
|
|
|
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, NONDELETION TYPE, X-LINKED
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
42
|
32
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Carcinoma, Signet Ring Cell
|
disease |
Neoplasms
|
Neoplastic Process
|
70
|
6
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Childhood Acute Monocytic Leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
70
|
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
Adult Acute Monocytic Leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
70
|
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
Psychotic symptom
|
phenotype |
|
Sign or Symptom
|
86
|
21
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
M5b Acute differentiated monocytic leukemia
|
disease |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
122
|
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
Somatic mutation
|
phenotype |
|
Cell or Molecular Dysfunction
|
151
|
|
0.100 |
None |
|
0 |
|
|
|
Juvenile Myelomonocytic Leukemia
|
disease |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
179
|
70
|
0.600 |
limited |
|
0 |
1
|
|
|
Adult Myelodysplastic Syndrome
|
disease |
Hemic and Lymphatic Diseases
|
Neoplastic Process
|
332
|
20
|
0.020 |
None |
0.500 |
2 |
|
2006 |
2011 |
Childhood Myelodysplastic Syndrome
|
disease |
Hemic and Lymphatic Diseases
|
Neoplastic Process
|
335
|
20
|
0.020 |
None |
0.500 |
2 |
|
2006 |
2011 |
Cerebellar Ataxia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Disease or Syndrome
|
441
|
120
|
0.030 |
None |
1.000 |
3 |
|
2015 |
2018 |
Mental Retardation
|
disease |
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases; Mental Disorders; Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
505
|
98
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Patent ductus arteriosus
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Cardiovascular Diseases
|
Congenital Abnormality
|
510
|
56
|
0.020 |
None |
1.000 |
2 |
|
2015 |
2019 |
Psychotic Disorders
|
group |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
560
|
179
|
0.300 |
None |
1.000 |
1 |
|
2015 |
2015 |
Eosinophil count procedure
|
phenotype |
|
Laboratory Procedure
|
610
|
1144
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Acute monocytic leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
633
|
22
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
White Blood Cell Count procedure
|
phenotype |
|
Laboratory Procedure
|
681
|
1322
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Hematologic Neoplasms
|
group |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
827
|
60
|
0.010 |
None |
1.000 |
1 |
|
2000 |
2000 |
Systolic Pressure
|
phenotype |
|
Clinical Attribute
|
843
|
1931
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |